← Open Payments lookup

KATY MILLER: Open Payments

NPI 1487285839 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,140 in 75 payments from 15 companies in 2025. Trend: 2023 $438 · 2024 $784 · 2025 $2,140

Food & beverage: $2,140
CompanyPaymentsAmount
ABBVIE INC.22$475
Novo Nordisk Inc13$444
Insulet Corporation2$230
Amgen Inc.12$219
AstraZeneca Pharmaceuticals LP4$201
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$132
Phathom Pharmaceuticals, Inc.2$122
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$98
Astellas Pharma US Inc3$74
Otsuka America Pharmaceutical, Inc.1$29

Products named: QULIPTA, OMNIPOD, Wegovy, Ozempic, VRAYLAR, CAPLYTA, EVENITY, VOQUEZNA.

Industry payments across MA — which companies pay providers there.